## ULTA: Ulta Beauty, Inc. - XLY: Consumer Cyclical

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 4.6% in lower entry zone (4.0-10.0%), top quartile (85th pct) cross-sectional ranking. Short-term MRS_5 (2.7%) confirms momentum alignment. Strong momentum (+2.2% 5-day acceleration). Outperforming sector by 4.9%. Caution: overbought RSI (71).

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($601.73)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 6
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. EXCLUSIVE: Rare Beauty to Launch Nationwide at Ulta Beauty**
- Source: WWD | 20260105T130314 | Bullish | Relevance: 100%
- Selena Gomez’s Rare Beauty is set to launch nationwide at Ulta Beauty on February 1, expanding its reach beyond Sephora to over 1,500 stores and ulta.com. This move aims to increase accessibility for the brand, which reported $400 million in sales in 2024 and is valued at over $2 billion. The partnership will also include a guest donation initiative benefiting both the Ulta Beauty Charitable Foundation and the Rare Impact Fund.

**2. What Ulta Beauty (ULTA)'s 'Ulta Beauty Unleashed' Store Revamp Means For Shareholders**
- Source: Simply Wall Street | 20260104T205357 | Neutral | Relevance: 100%
- Ulta Beauty launched "Ulta Beauty Unleashed" to enhance in-store experiences and expand into international markets, aiming to diversify sales and reinforce its physical store model against online rivals. This initiative supports Ulta's strategy of offering experiential shopping and a broader product range, including the new UB Marketplace, while the company faces potential cost inflation and the eventual loss of its Target partnership. The article examines how this revamp could reshape Ulta Beauty’s investment narrative, with projected revenues of $13.8 billion and earnings of $1.3 billion by 2028, but also highlights investor concerns about rising operating costs and varying fair value estimates.

**3. Rare Beauty by Selena Gomez to Launch Nationwide in Ulta Beauty**
- Source: PR Newswire | 20260105T090000 | Bullish | Relevance: 100%
- Rare Beauty by Selena Gomez is expanding its retail presence by launching into over 1500 Ulta Beauty stores and Ulta.com starting February 1, 2026. This expansion includes a unique donation partnership where 50% of guest contributions at checkout will go to the Ulta Beauty Charitable Foundation and 50% to the Rare Impact Fund, supporting youth mental health. The collaboration aims to make Rare Beauty's mission of self-acceptance and its popular products more accessible to a wider audience.

**4. Precision Trading with Ulta Beauty Inc. (ULTA) Risk Zones**
- Source: Stock Traders Daily | 20260103T160200 | Neutral | Relevance: 100%
- This article presents a precision trading analysis for Ulta Beauty Inc. (ULTA), highlighting neutral near and mid-term readings that could moderate its long-term positive bias. It identifies an exceptional 26.5:1 risk-reward short setup and provides institutional trading strategies for different risk profiles, including position trading, momentum breakout, and risk hedging. The analysis is supported by AI-generated signals for multi-timeframe insights.

**5. Ações da Ulta Beauty atingem máxima histórica de US$ 616,51**
- Source: Investing.com Brasil - Finanças, Câmbio e Investimentos | 20260103T140853 | Bullish | Relevance: 100%
- As ações da Ulta Beauty atingiram uma nova máxima histórica de US$ 616,51, superando sua máxima de 52 semanas. A empresa demonstrou um retorno total de 40,98% no último ano, impulsionado por um crescimento bem-sucedido e estratégica adaptação ao mercado, embora esteja ligeiramente sobrevalorizada em comparação com seu Valor Justo. A Ulta Beauty também tem sido alvo de análises positivas de Wall Street e implementou um novo plano de indenização para executivos.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 4, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2026-01-02 | Argus Research | $700 | $650 | +8% |
| 2025-12-10 | Oppenheimer | $675 | $615 | +10% |
| 2025-12-08 | Morgan Stanley | $640 | $600 | +7% |
| 2025-12-08 | TD Cowen | $725 | $600 | +21% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2026-01-02 | Argus Research | main | Buy |
| 2025-12-10 | Oppenheimer | main | Outperform |
| 2025-12-08 | Morgan Stanley | main | Overweight |
| 2025-12-08 | TD Cowen | up | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **MIXED** |
| Buys | 1 ($0.00M) |
| Sells | 1 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 45.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 12.1% (+0.6%)
- Blackrock Inc.: 9.0% (-2.1%)
- JPMORGAN CHASE & CO: 5.5% (+99.0%)
- State Street Corpora: 4.4% (+2.3%)
- Sanders Capital, LLC: 2.8% (+8.9%)

### Key Risks

1. Volume divergence: price rising (+2.2% MRS) on declining volume (62% of avg) suggests distribution.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Analyst target momentum: 4 raises (avg +11%) could attract flows.
- Momentum building: MRS_20 improving +2.2% over 5 days suggests accumulation.

### Fundamentals

PEG ratio 2.44 elevated, pricing in significant growth expectations. Forward P/E 22.3x stretched relative to 11% growth. Quality metrics strong (ROE 48%, ROA 15%). Analyst sentiment positive (4 raises, avg +11%). Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $28.3B |
| Beta | 0.85 |
| 52W Range | $309.01 - $636.96 |
| Short Interest | 6.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.44 |
| Forward P/E | 22.3 |
| Current P/E | 24.7 |
| YoY Growth | 10.7% |
| EPS Direction | STABLE |

### Technicals

MRS_20 strengthening from 2.4% to 4.6% (+2.2% in 5 days), confirming momentum buildup. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 85th percentile. MRS_5 at 2.7% confirms short-term momentum alignment. AM_20 at 4.8% shows strong absolute momentum above own 20MA. Outperforming sector by 4.9pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 71, risk of mean reversion. OFD pattern: +MUN (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 4.62% (CS: 85) | Strong |
| RSI_14 | 71.0 | Overbought |
| MACD Histogram | 0.36 | Bullish |
| vs SMA20 | 1.048x | Above |
| vs SMA50 | 1.139x | Above |
| vs SMA200 | 1.291x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $631.15
- **Stop Loss:** $601.73 (4.7% risk)
- **Target:** $675.28 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 39
- **Position Value:** $24,614.85
- **Portfolio %:** 24.61%
- **Risk Dollars:** $1,150.00
- **Risk Per Trade:** 1.15%
- **Modifiers:** L1 115% | L2 100% | Combined 1.15x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-03-12 (Est: $7.15)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $4.60 | $5.14 | +11.7% |
| 2025Q3 | $5.04 | $5.78 | +14.6% |
| 2025Q2 | $5.80 | $6.70 | +15.5% |
| 2025Q1 | $7.15 | $8.46 | +18.4% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*